Comprehensive Analysis of the Prognostic Significance of the TRIM Family in the Context of TP53 Mutations in Cancers

被引:2
|
作者
Vu, Trung [1 ]
Fowler, Annaliese [2 ]
McCarty, Nami [2 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis IMM, Ctr Stem Cell & Regenerat Dis, Houston, TX 77030 USA
[2] Texas A&M Univ, Dept Biomed Engn, Houston, TX 77030 USA
关键词
TP53; liver cancer; TRIM family; cell cycle; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; GENE-EXPRESSION; P53; MICRORNAS; SURVIVAL; PROMOTES; MIR-34A;
D O I
10.3390/cancers15153792
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The p53 protein is an important tumor suppressor, and TP53 mutations are frequently low survival rates of cancer patients. Mutations in TP53 lead in loss of tumor suppressing functions which result in the development of tumors. Meanwhile, several tripartite motif (TRIM) proteins are known to regulate cell growth and cell cycle transition. However, the relationship between TRIM family genes and TP53 mutations in cancer remains unknown. In this study, we analyzed the links between TP53 mutations and TRIM family proteins and evaluated the role of TRIM family proteins in cancer patients with TP53 mutation. Our findings identified the TRIM family members that are highly expressed in TP53 mutant tumors and important for the cell growth in the context of TP53 mutations. The p53 protein is an important tumor suppressor, and TP53 mutations are frequently associated with poor prognosis in various cancers. Mutations in TP53 result in a loss of p53 function and enhanced expression of cell cycle genes, contributing to the development and progression of cancer. Meanwhile, several tripartite motif (TRIM) proteins are known to regulate cell growth and cell cycle transition. However, the prognostic values between TP53 and TRIM family genes in cancer are unknown. In this study, we analyzed the relationship between the TP53 mutations and TRIM family proteins and evaluated the prognostic significance of TRIM family proteins in cancer patients with P53 mutations. Our findings identified specific TRIM family members that are upregulated in TP53 mutant tumors and are associated with the activation of genes related to a cell-cycle progression in the context of TP53 mutations.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
    Kyndi, M
    Alsner, J
    Hansen, LL
    Sorensen, FB
    Overgaard, J
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S54 - S54
  • [22] Independent prognostic significance of TP53 mutations in adult acute myeloid leukaemia with complex karyotype
    Xu, Nan
    Lai, Yue-Yun
    Chen, Wen-Min
    Jiang, Hao
    Wang, Yu
    Wang, Xu
    Zhao, Xiao-Su
    Huang, Xiao-Jun
    Jiang, Qian
    Qin, Ya-Zhen
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (05) : 892 - 899
  • [23] Truncating TP53 mutations have prognostic significance in head and neck squamous cell carcinoma
    van der Plas, Marlon
    Brakenhoff, Ruud H.
    Kuik, Dirk J.
    Buijze, Marijke
    Bloemena, Elisabeth
    Snijders, Peter Jf
    Leemans, C. Rene
    Braakhuis, Boudewijn Jm
    CANCER RESEARCH, 2011, 71
  • [24] The Prognostic Significance of TP53 Mutations for Overall Outcome in Lower-Risk MDS Patients
    Belickova, Monika
    Vesela, Jitka
    Jonasova, Anna
    Stara, Eliska
    Planetova, Barbora
    Zemanova, Zuzana
    Brezinova, Jana
    Mikulenkova, Dana
    Cermak, Jaroslav
    BLOOD, 2014, 124 (21)
  • [25] Characterization of TP53 mutations in clonal cytopenia of undetermined significance
    Wang, Wei
    Routbort, Mark J.
    Ok, Chi Young
    Patel, Keyur P.
    Sun, Yi
    Kanagal-Shamanna, Rashmi
    Medeiros, L. Jeffrey
    Wang, Sa A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E175 - E177
  • [26] TP53 mutations are not prognostic independent indicators in bladder cancer
    Agnese, V.
    Corsale, S.
    Augello, C.
    Bruno, L.
    Calo, V.
    Cammareri, P.
    Cascio, S.
    Gargano, G.
    Gregorio, V.
    Gullo, A.
    La Rocca, G.
    Sisto, P. S.
    Valerio, M. R.
    Di Fede, G.
    Martorana, A.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2005, 16 : 152 - 152
  • [27] TP53 mutations as a prognostic factor in women with breast cancer
    Marie Lofthouse
    Nature Clinical Practice Oncology, 2005, 2 (9): : 428 - 429
  • [28] TP53 Mutations in Endometrial Cancers Relation to PTEN Gene Defects
    Janiec-Jankowska, Aneta
    Konopka, Bozena
    Goluda, Cyprian
    Najmola, Urszula
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (02) : 196 - 202
  • [29] TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
    Olivier, Magali
    Hollstein, Monica
    Hainaut, Pierre
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (01): : a001008
  • [30] Relative frequency and morphology of cancers in carriers of germline TP53 mutations
    Jillian M Birch
    Robert D Alston
    Richard JQ McNally
    D Gareth R Evans
    Anna M Kelsey
    Martin Harris
    Osborn B Eden
    Jennifer M Varley
    Oncogene, 2001, 20 : 4621 - 4628